BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 12812824)

  • 1. Geographic variation within the United States in the incidence of hepatocellular carcinoma.
    Davila JA; Petersena NJ; Nelson HA; El-Serag HB
    J Clin Epidemiol; 2003 May; 56(5):487-93. PubMed ID: 12812824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of race and ethnicity on thyroid cancer incidence.
    Magreni A; Bann DV; Schubart JR; Goldenberg D
    JAMA Otolaryngol Head Neck Surg; 2015 Apr; 141(4):319-23. PubMed ID: 25654447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in incidence rates of tobacco-related cancer, selected areas, SEER Program, United States, 1992-2004.
    Polednak AP
    Prev Chronic Dis; 2009 Jan; 6(1):A16. PubMed ID: 19080022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatocellular Carcinoma Incidence Is Decreasing Among Younger Adults in the United States.
    Rich NE; Yopp AC; Singal AG; Murphy CC
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):242-248.e5. PubMed ID: 31042582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changing hepatocellular carcinoma incidence and liver cancer mortality rates in the United States.
    Altekruse SF; Henley SJ; Cucinelli JE; McGlynn KA
    Am J Gastroenterol; 2014 Apr; 109(4):542-53. PubMed ID: 24513805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update.
    El-Serag HB; Davila JA; Petersen NJ; McGlynn KA
    Ann Intern Med; 2003 Nov; 139(10):817-23. PubMed ID: 14623619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Geographic Variations in the Incidence of Glioblastoma and Prognostic Factors Predictive of Overall Survival in US Adults from 2004-2013.
    Xu H; Chen J; Xu H; Qin Z
    Front Aging Neurosci; 2017; 9():352. PubMed ID: 29163134
    [No Abstract]   [Full Text] [Related]  

  • 8. Race/ethnicity-specific disparities in cancer incidence, burden of disease, and overall survival among patients with hepatocellular carcinoma in the United States.
    Ha J; Yan M; Aguilar M; Bhuket T; Tana MM; Liu B; Gish RG; Wong RJ
    Cancer; 2016 Aug; 122(16):2512-23. PubMed ID: 27195481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of hepatocellular carcinoma in Hispanics in the United States.
    El-Serag HB; Lau M; Eschbach K; Davila J; Goodwin J
    Arch Intern Med; 2007 Oct; 167(18):1983-9. PubMed ID: 17923599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Impact of Race on Survival After Hepatocellular Carcinoma in a Diverse American Population.
    Jones PD; Diaz C; Wang D; Gonzalez-Diaz J; Martin P; Kobetz E
    Dig Dis Sci; 2018 Feb; 63(2):515-528. PubMed ID: 29275448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: Implications for prevention.
    Yang B; Liu JB; So SK; Han SS; Wang SS; Hertz A; Shariff-Marco S; Lin Gomez S; Rosenberg PS; Nguyen MH; Hsing AW
    Cancer; 2018 Sep; 124(17):3551-3559. PubMed ID: 30113700
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of Hepatocellular Carcinoma in All 50 United States, From 2000 Through 2012.
    White DL; Thrift AP; Kanwal F; Davila J; El-Serag HB
    Gastroenterology; 2017 Mar; 152(4):812-820.e5. PubMed ID: 27889576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C infection and the increasing incidence of hepatocellular carcinoma: a population-based study.
    Davila JA; Morgan RO; Shaib Y; McGlynn KA; El-Serag HB
    Gastroenterology; 2004 Nov; 127(5):1372-80. PubMed ID: 15521006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors associated with suicide among hepatocellular carcinoma patients: A surveillance, epidemiology, and end results analysis.
    Chen C; Jiang Y; Yang F; Cai Q; Liu J; Wu Y; Lin H
    Eur J Surg Oncol; 2021 Mar; 47(3 Pt B):640-648. PubMed ID: 33051117
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circadian Misalignment and Hepatocellular Carcinoma Incidence in the United States.
    VoPham T; Weaver MD; Vetter C; Hart JE; Tamimi RM; Laden F; Bertrand KA
    Cancer Epidemiol Biomarkers Prev; 2018 Jul; 27(7):719-727. PubMed ID: 29636342
    [No Abstract]   [Full Text] [Related]  

  • 16. Sex and Race Disparities in the Incidence of Hepatocellular Carcinoma in the United States Examined through Age-Period-Cohort Analysis.
    Zhang X; El-Serag HB; Thrift AP
    Cancer Epidemiol Biomarkers Prev; 2020 Jan; 29(1):88-94. PubMed ID: 31712271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of curative intent surgery on the survival of pancreatic cancer patients: a U.S. Population-based study.
    Shaib Y; Davila J; Naumann C; El-Serag H
    Am J Gastroenterol; 2007 Jul; 102(7):1377-82. PubMed ID: 17403071
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disparities in Hepatocellular Carcinoma Incidence, Stage, and Survival: A Large Population-Based Study.
    Flores YN; Datta GD; Yang L; Corona E; Devineni D; Glenn BA; Bastani R; May FP
    Cancer Epidemiol Biomarkers Prev; 2021 Jun; 30(6):1193-1199. PubMed ID: 33737301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatocellular carcinoma: recent trends in the United States.
    El-Serag HB
    Gastroenterology; 2004 Nov; 127(5 Suppl 1):S27-34. PubMed ID: 15508094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatocellular carcinoma - United States, 2001-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 May; 59(17):517-20. PubMed ID: 20448528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.